What is the market price of pomalidomide?

Pomalidomide, as an innovative immunomodulator, has been widely used in the treatment of multiple myeloma worldwide. Multiple myeloma is a malignant plasma cell disease characterized by abnormal proliferation of plasma cells in the bone marrow and overproduction of monoclonal immunoglobulins or light chains. This disease often leads to a series of serious symptoms such as bone destruction, kidney function damage, and anemia, posing a serious threat to the patient's quality of life.

The emergence of pomalidomide has brought new treatment hope to patients with multiple myeloma. It has been shown to be effective, primarily in combination with dexamethasone, in adults who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and whose disease has progressed during or within 60 days of the last treatment. Pomalidomide can inhibit the proliferation of tumor cells and induce their apoptosis, thereby effectively controlling the progression of the disease and prolonging the survival of patients.

Domestically, pomalidomide is already on the market and has been included in medical insurance reimbursement items, which has greatly reduced the financial burden on patients. However, it is worth noting that the medical insurance reimbursement ratios vary in different regions, so you need to consult the local medical insurance reimbursement department for specific prices. At the same time, the prices of generic drugs of the same specifications in overseas markets are lower, which also provides patients with more choices.

Of course, the use of any drug comes with certain risks. Pomalidomide is no exception, it may cause some side effects, such as neutropenia, anemia, etc. Therefore, before using pomalidomide, patients must consult a professional doctor to ensure that the drug is used rationally under the guidance of a doctor, and undergo regular physical examination and monitoring to ensure the safety and effectiveness of the treatment.

Pomalidomide is now on the market in China and has been included in the scope of medical insurance reimbursement. Based on the specification of 4mg*21 tablets, after reimbursement by medical insurance, the domestic price is about 5,000 yuan. However, it should be noted that the reimbursement ratio varies in different places. For details, please consult the local medical insurance reimbursement agency. In comparison, the prices of generic drugs of the same specifications in overseas markets are more affordable. For example, the products of Laos ASEAN Pharmaceuticals are only about 650 yuan, while the prices of Indian NATCO are only about 2,200 yuan. For more information about pomalidomide, it is recommended to consult a regular overseas medical consulting company.

xa0

Reference materials:https://www.drugs.com/mtm/pomalidomide.html